Atika Capital Management LLC Amicus Therapeutics, Inc. Transaction History

Atika Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$10.96 - $14.4 $1.81 Million - $2.38 Million	-165,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$10.04 - $13.92 $1.66 Million - $2.3 Million	165,000 New	165,000 $2.24 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $1.31 Million - $1.71 Million	-100,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.38 Million - $1.71 Million	100,000 New	100,000 $1.5 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.